Sublingual Immunotherapies: The more we know, the more we need to know
págs. 213-215
The contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: A real-life randomised trial
M. Marogna, C. Braidi, M.E. Bruno, F. Colombo, A. Massolo, C. Colombo, L. Palumbo, E. Compalati
págs. 216-224
págs. 225-232
First annual register of allergenic pollen in Talca, Chile
P. Mardones, M. Grau, J. Araya, A. Córdova, I. Pereira, P. Peñailillo, R. Silva, A. Moraga, Raquel Aguilera Insunza, J.J. Yepes Núñez, Iván Palomo González
págs. 233-238
págs. 239-245
págs. 246-254
Common features of anaphylaxis in children
M. Serbes, D. Can, F. Atlihan, I. Günay, S. Asilsoy, S. Altinöz
págs. 255-260
Asthma and paracetamol: Could we really know what happens between them?
Luis Moral Gil, N. Marco, María Jesús Fuentes Bonmatí, T. Toral, R. Caño, María Ángeles Pena Pardo
págs. 261-264
Allergen-specific immunotherapy: Update on immunological mechanisms
M. Álvaro Lozano, Juan Sancha Pacheco, H. Larramona, J.M Lucas, María Mesa del Castillo Payá, Ana Isabel Tabar Purroy, Ana Martínez-Cañavate Burgos
págs. 265-272
Allergy shots: Do patients feel pain or fear?
págs. 273-275
págs. 275-276
Is age associated with the development of antibodies against botulinum toxin?
M. Vivolo Aun, T.M. Chung, K.S. Santos, L.M.R. Battistella, L.V. Rizzo, Jorge Kalil, P. Giavina-Bianchi
págs. 276-279
págs. 279-281
Coexistence of allergic bronchopulmonary aspergillosis and atopic dermatitis: Is total IgE level useful to identify relapses of allergic bronchopulmonary aspergillosis?
págs. 281-283
págs. 283-284
© 2001-2024 Fundación Dialnet · Todos los derechos reservados